Phase 1, Randomized, Masked, Sham-Controlled Study to Assess the Safety and Tolerability of EO2002 in Subjects Undergoing Cataract Surgery
Status: Recruiting
Location: See location...
Intervention Type: Biological, Other
Study Type: Interventional
Study Phase: Phase 1
SUMMARY
The goal of this clinical study is to assess the safety of intracameral injection of EO2002 in subjects post-cataract surgery.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Age ≥ 18 years.
• Subject has uncomplicated history of cataract that has progressed to a level requiring standard cataract extraction with intraocular lens implant surgery.
• Decreased endothelial cell count
Locations
Other Locations
Mexico
Asociacion para Evitar la Ceguera en Mexico
RECRUITING
Mexico City
Contact Information
Primary
Yara Luna
reclutamiento.proyectos@apec.com.mx
55 39 53 12 25
Time Frame
Start Date: 2022-08-30
Estimated Completion Date: 2026-10-06
Participants
Target number of participants: 32
Treatments
Experimental: Treatment at time of surgery
EO2002 intracameral injection
Experimental: Treatment post surgery
EO2002 intracameral injection
Active_comparator: Treatment at time of or post surgery
EO2002 intracameral injection
Sham_comparator: Sham injection at time of or post surgery
Sham injection
Related Therapeutic Areas
Sponsors
Collaborators: Emmecell
Leads: Asociación para Evitar la Ceguera en México